New device to replace aortic valve in patients who can't have open-heart surgery
Wednesday, August 15, 2012 - 15:30
in Health & Medicine
UCLA has performed its first transcatheter aortic valve replacement (TAVR), using a new device approved by the U.S. Food and Drug Administration to replace an aortic valve in a patient who was not a candidate for open-heart surgery.